Randomized, Double-Blind, Placebo-Controlled, Phase I Dose-Escalation Study of Single Dose GHB01L1 in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 25 Apr 2014
At a glance
- Drugs Influenza virus delta-NS1 vaccine (Primary)
- Indications Influenza A virus infections; Influenza virus infections
- Focus Adverse reactions
- Sponsors AVIR Green Hills Biotechnology
- 14 Jan 2010 Results were presented in the Journal of Infectious Diseases.
- 09 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Dec 2009 Actual end date (Aug 2008) added as reported by ClinicalTrials.gov.